Similar to non-ccRCC with sarcomatoid differentiation, subclonal TP53 mutations could also be a first molecular step into the development of an aggressive phenotype of ccRCC leading to sarcomatoid differentiation. Here, TP53 is linked to nonpapillary renal cell carcinoma.